Aspirin and mortality from coronary bypass surgery [1] (multiple letters)

New England Journal of Medicine

Volumn 348, Issue 11, 2003, Pages 1057-1059

  Chesebro, James H ^a   Fuster, Valentin ^b   Pugo, Francisco J ^c   Karzai, Waheedullah ^d   Priebe, Hans Joachim ^e   Mangano, Dennis T ^f  

^a MAYO CLINIC   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC ROCHESTER   (United States)

^d ZENTRALKLINIK BAD BERKA   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f Ischemia Research and Education Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ARTIFICIAL VENTILATION; BLEEDING; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; GRAFT OCCLUSION; HUMAN; LETTER; MORTALITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; REOPERATION; THROMBOSIS; NOTE; POSTOPERATIVE COMPLICATION; STANDARD; METHODOLOGY;

ASPIRIN; CORONARY ARTERY BYPASS; HUMAN; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; THROMBOSIS; HUMANS; RESEARCH DESIGN;

EID: 0037435095     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200303133481114     Document Type: Letter

References (0)